MedTrace Logo

The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

NCT04214002 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-09-17

No results posted yet for this study

Summary

This study is a non-interventional, observational study that will evaluate the natural history of wounds in patients with Dystrophic Epidermolysis Bullosa (DEB) for inclusion into the Krystal Biotech Phase III protocol of B-VEC (previously KB103). Wound recurrence and wound size will be evaluated for up to four months.

Conditions

  • Dystrophic Epidermolysis Bullosa
  • DEB - Dystrophic Epidermolysis Bullosa

Sponsors & Collaborators

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2020-02-24
Completion
2020-02-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04214002 on ClinicalTrials.gov